Market Research Analysis In Situ Hybridization Market Share, Distributor | Page 2

Rising prevalence of cancer-related diseases is expected to boost market demand for In Situ hybridization over the
upcoming years. In addition, increasing adoption of DNA probe-based diagnostics for identification of diseases that
are caused by pathogen or bacteria is estimated to drive market growth. Rise in the number of incidence related to
genetic disorders, solid tumors, leukemia, autism, and other syndromes are predicted to stimulate market demand for
In Situ hybridization over the forecast period.
The market is broadly categorized into major four segments based on the product type such as instruments, kits &
probes, software and services. The instruments is considered as one of the fastest growing segment in the In Situ
hybridization market with substantial revenue generation in the last few years. Growing popularity of the instruments
segment among healthcare professionals is attributed to the rise in the demand from diagnostic and research
laboratories. The kits & probes segment has also witnessed substantial growth owing to the growing incidence of
target disorders such as cancer.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market-share/request-sample
The market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has
shown major growth in recent years owing to the rise in the implementation of latest technologies in pharmaceuticals
& medicine sector, higher penetration rates, increase in the demand for disposable devices from healthcare
professionals, and existence of well-established infrastructure.
Asia-Pacific region is predicted to hold major market share in the In Situ hybridization market with massive growth in
forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with increasing
healthcare expenditure, growing prevalence of cancer related diseases, presence of high-unmet patient needs, and
significant investment by leading industry players considering potential growth opportunities in the region.
The key players in the In Situ hybridization market are Thermo Fisher Scientific Co., Leica BiosystemsNussloch GmbH,
BIOVIEW, Inc., Agilent Technologies, Inc., Merck KGaA, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., NeoGenomics
Laboratories, Inc., Advanced Cell Diagnostics, Inc., and Oxford Gene Technology Co.
Market Segment:
Market Leaders
• Leica Biosystems Nussloch GmbH
• Thermo Fisher Scientific
• F. Hoffmann-La Roche AG